CNY 8.18
(0.62%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
---|---|---|---|---|---|---|
Operating Cash Flow | -3.34 Million | -252.52 Thousand | 20.3 Million | 154.33 Million | -9.2 Million | 78.96 Million |
Net Income | -127.35 Million | -121.62 Million | -754.34 Million | 47.7 Million | -519.18 Million | 10.98 Million |
Depreciation & Amortization | 27.01 Million | 27.58 Million | 28.33 Million | 12.75 Million | 3.23 Million | 2.81 Million |
Deferred income taxes | -45.17 Million | -7.52 Million | -22.24 Million | -16.38 Million | 19.65 Million | -9.89 Million |
Stock-based compensation | - | - | - | - | -826.68 Thousand | -57.42 Thousand |
Change in working capital | -15.11 Million | 1.84 Million | 31.08 Million | -2.25 Million | 19.95 Million | -38.56 Million |
Other non-cash items | 15.07 Million | 91.94 Million | 715.22 Million | 96.14 Million | 467.96 Million | 103.73 Million |
Investing Cash Flow | 386.19 Thousand | 388.02 Thousand | -43.93 Million | -76.32 Million | -179.72 Million | -189.08 Million |
Investments in PPE | -3786.72 | -2.14 Million | -185.88 Thousand | -41.16 Million | -25.72 Million | -22.52 Million |
Acquisitions | 389.98 Thousand | 2.82 Million | -57.75 Million | -53.62 Million | -164.12 Million | -166.86 Million |
Investment purchases | - | - | -2 Million | 53.28 Thousand | 26.45 Million | 22.81 Million |
Sales/Maturities of investments | - | - | 0.27 | 19.91 Million | 9.4 Million | 19.27 Thousand |
Other Investing Activities | 389.98 Thousand | -290 Thousand | 16 Million | -1.51 Million | -25.72 Million | -22.52 Million |
Financing Cash Flow | 511.24 Million | -39.93 Million | 54.37 Million | -136.71 Million | 50.26 Million | 128.43 Million |
Debt repayment | -1002.63 | -14.35 Million | -156.77 Million | -345.84 Million | -283.46 Million | -386.24 Million |
Dividends payments | -3.08 Million | -9.62 Million | -14.59 Million | -15.32 Million | -11.69 Million | -11.95 Million |
Common Stock Repurchased | - | - | -402.87 Thousand | -845.64 Thousand | -13.78 Million | -23.49 Million |
Common Stock Issuance | - | - | 402.87 Thousand | 845.64 Thousand | 13.78 Million | -843.63 Thousand |
Other Financing Activities | 514.33 Million | -15.95 Million | 225.75 Million | 224.45 Million | 360.31 Million | 526.63 Million |
Accounts receivables | 14.29 Million | 4.94 Million | 132.6 Million | 338.14 Million | -67.21 Million | -137.35 Million |
Accounts payables | - | -4.94 Million | -132.6 Million | -338.14 Million | 67.21 Million | - |
Inventory | 14.11 Million | 2.71 Million | 4.5 Million | 50.3 Million | 40.26 Million | -24.88 Million |
Other working capital | 1.65 Million | -863.02 Thousand | 26.58 Million | -52.56 Million | -20.31 Million | -13.68 Million |
Cash at beginning of period | 625.45 Thousand | 40.42 Million | 9.67 Million | 68.38 Million | 207.06 Million | 188.72 Million |
Cash at end of period | 508.91 Million | 625.45 Thousand | 40.42 Million | 9.67 Million | 68.38 Million | 207.06 Million |
Capital Expenditure | -3786.72 | -2.14 Million | -185.88 Thousand | -41.16 Million | -25.72 Million | -22.52 Million |
Effect of forex changes on cash | - | 0.26 | - | - | -10.65 Thousand | 16.63 Thousand |
Net cash flow / Change in cash | 508.29 Million | -39.8 Million | 30.75 Million | -58.7 Million | -138.67 Million | 18.33 Million |
Free Cash Flow | -3.34 Million | -2.39 Million | 20.12 Million | 113.17 Million | -34.92 Million | 56.44 Million |
Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -22.74 Million | -4.65 Million | 1.85 Million | -127.35 Million | -78.72 Million | -26.2 Million |
Depreciation & Amortization | - | 5.49 Million | 5.49 Million | 27.01 Million | 27.01 Million | -12.21 Million |
Deferred income taxes | - | - | - | -45.17 Million | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | - | -15.11 Million | 28.4 Million | -25.12 Million |
Other non-cash items | -24.72 Million | 21.98 Million | -69.63 Million | 15.07 Million | 31.24 Million | 59.13 Million |
Investing Cash Flow | -19.42 Million | -1.54 Million | 100.00 | 386.19 Thousand | -51.64 Thousand | 405 Thousand |
Investments in PPE | -69.77 Thousand | -11.83 Million | - | -3786.72 | -3786.00 | - |
Acquisitions | - | - | 100.00 | 389.98 Thousand | -47.85 Thousand | 405 Thousand |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | -19.35 Million | -1.54 Million | 100.00 | 389.98 Thousand | -47.85 Thousand | 405 Thousand |
Financing Cash Flow | -23.36 Million | -54.75 Million | -128.94 Million | 511.24 Million | 500.4 Million | 3.8 Million |
Debt repayment | -39.34 Million | -39.34 Million | -85.09 Million | -1002.63 | -23.23 Thousand | -19.66 Thousand |
Dividends payments | - | -79.54 Thousand | -5.15 Million | -3.08 Million | -1.53 Million | -8193.00 |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -62.7 Million | -11.38 Million | -38.69 Million | 514.33 Million | 501.91 Million | 3.82 Million |
Accounts receivables | - | - | - | 14.29 Million | 14.29 Million | -24.77 Million |
Accounts payables | - | - | - | - | - | - |
Inventory | - | - | - | 14.11 Million | 14.11 Million | -352.17 Thousand |
Other working capital | - | - | - | 1.65 Million | - | - |
Cash at beginning of period | 273.02 Million | 345.48 Million | 508.91 Million | 625.45 Thousand | 637.97 Thousand | 846.8 Thousand |
Cash at end of period | 184.33 Million | 273.02 Million | 312.19 Million | 508.91 Million | 508.91 Million | 637.97 Thousand |
Capital Expenditure | -69.77 Thousand | -11.83 Million | - | -3786.72 | -3786.00 | - |
Effect of forex changes on cash | - | - | - | - | - | -0.39 |
Net cash flow / Change in cash | -88.69 Million | -72.46 Million | -196.72 Million | 508.29 Million | 508.27 Million | -208.83 Thousand |
Free Cash Flow | -47.53 Million | - | -67.77 Million | -3.34 Million | 7.92 Million | -4.41 Million |
002025
RLI
300155
MFCO
MRKV
BALKRISIND